Elevance Health Inc (ELV) Q4 2024 Earnings Call Highlights: Strong EPS and Revenue Growth Amid ...
Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, despite challenges in Medicaid cost trends.
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.Nathan Rich -- Vice President, Investor Relations Good morning,
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.
Elevance Health expects to grow MA membership by at least 7% in 2025
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,
Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say
For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $44.
Elevance Health Q4 earnings miss estimates, stock rises
The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue came in at $45 billion, slightly above the $44.9 billion analysts had projected and up 6% year-over-year.
Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond
Q4 2024 Elevance Health Inc Earnings Call
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.
Elevance Health reports Q4 adjusted EPS $3.84, consensus $3.86
Reports Q4 revenue $45B, consensus $44.72B. “As part of our commitment to elevating whole health and advancing health beyond healthcare, we
Elevance Health Q4 Ad. EPS Miss Market, Revenues Beat; Sees Growth In FY25, Lifts Dividend; Stock Up
Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...
Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.
GreensKeeper Value Fund Q4 2024 Letter
The GreensKeeper Value Fund finished the year 2024 +23.6% net of fees and expenses. Click here to read the full fund letter.
Ann Hynes Recommends ‘Buy’ on Elevance Health Due to Strong Growth Potential and Strategic Guidance
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on ELV stock, giving a Buy rating on January 16.Invest with ...